Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Granger

Showing results (81-90 of 1,253) with videos related to

Pageof 126
Sort By:
AACN Advanced Critical Care|October 26, 2012
Engaging research partners to advance clinical inquiryJanet Prvu Bettger, Bradi B Granger
Circulation|August 17, 2011
The need for regional integrated care for ST-segment elevation myocardial infarctionJohn P Vavalle, Christopher B Granger
European Heart Journal|June 7, 2019
Continuous anticoagulation with catheter ablation: answers and questionsSean D Pokorney, Christopher B Granger
Annals of Internal Medicine|March 21, 2017
Guideline: The USPSTF recommends low- to moderate-dose statins to prevent CVD in selected adults 40 to 75 years of ageNeha J Pagidipati, Christopher B Granger
American Heart Journal|August 23, 2006
Reflections on early stopping of a clinical trialPaul W Armstrong, Christopher B Granger
JAMA|May 3, 2007
Pexelizumab and the APEX AMI trialPaul W Armstrong, Christopher B Granger
European Heart Journal|January 23, 2010
Clinical trials and registries in cardiovascular disease: competitive or complementary?Christopher B Granger, Bernhard J Gersh
Annals of Internal Medicine|January 21, 2020
In patients with recent ACS and uncontrolled dyslipidemia, alirocumab reduced MACE regardless of previous CABGAnthony P Carnicelli, Christopher B Granger
Current Heart Failure Reports|July 12, 2014
Racial disparities and the use of technology for self-management in blacks with heart failure: a literature reviewHannah Anderson Hughes, Bradi B Granger
Annals of Internal Medicine|February 17, 2016
ACP Journal Club. In atrial fibrillation, the ATRIA risk score better predicted stroke than CHADS2 and CHA2DS2-VASc scoresBrandon W Calenda, Christopher B Granger
Pageof 126

Showing results (81-90 of 1,253) with videos related to

Sort By:
Pageof 126
AACN Advanced Critical Care|October 26, 2012
Engaging research partners to advance clinical inquiryJanet Prvu Bettger, Bradi B Granger
Circulation|August 17, 2011
The need for regional integrated care for ST-segment elevation myocardial infarctionJohn P Vavalle, Christopher B Granger
European Heart Journal|June 7, 2019
Continuous anticoagulation with catheter ablation: answers and questionsSean D Pokorney, Christopher B Granger
Annals of Internal Medicine|March 21, 2017
Guideline: The USPSTF recommends low- to moderate-dose statins to prevent CVD in selected adults 40 to 75 years of ageNeha J Pagidipati, Christopher B Granger
American Heart Journal|August 23, 2006
Reflections on early stopping of a clinical trialPaul W Armstrong, Christopher B Granger
JAMA|May 3, 2007
Pexelizumab and the APEX AMI trialPaul W Armstrong, Christopher B Granger
European Heart Journal|January 23, 2010
Clinical trials and registries in cardiovascular disease: competitive or complementary?Christopher B Granger, Bernhard J Gersh
Annals of Internal Medicine|January 21, 2020
In patients with recent ACS and uncontrolled dyslipidemia, alirocumab reduced MACE regardless of previous CABGAnthony P Carnicelli, Christopher B Granger
Current Heart Failure Reports|July 12, 2014
Racial disparities and the use of technology for self-management in blacks with heart failure: a literature reviewHannah Anderson Hughes, Bradi B Granger
Annals of Internal Medicine|February 17, 2016
ACP Journal Club. In atrial fibrillation, the ATRIA risk score better predicted stroke than CHADS2 and CHA2DS2-VASc scoresBrandon W Calenda, Christopher B Granger
Pageof 126